Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.04 USD | +2.87% | +9.37% | +9.97% |
05-03 | Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target | MT |
03-07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.97% | 571M | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- PHAT Stock
- News Phathom Pharmaceuticals, Inc.
- Phathom Pharmaceuticals : BMO Capital Starts Phathom Pharmaceuticals at Outperform With $63 Price Target